Berkay completed a Master of International Relations at the University of Melbourne in 2015 before working in a number of research and communication roles. Prior to joining Proactive Investors in 2018, Berkay worked as a researcher and reporter in the mining industry, focusing on Australia and Africa. He has a strong interest in global affairs and the politics of mining.
MMJ is the only ASX-listed investment company offering Australian investors the opportunity to invest in unlisted and listed cannabis-related businesses locally and offshore.
The study will mark the fourth ongoing clinical trial for Kazia's GDC-0084 drug candidate, with each trial treating different forms of brain cancer.
Despite increased levels of exploration funding globally, the number of major new copper discoveries has declined and is forecast to remain historically low.
The company will begin recruitment for the upcoming dose expansion cohort immediately.
The company is waiting final licencing and permitting approvals to begin manufacturing at its Canndeo site in Canada.
The halt will remain in place until the start of trading on Friday or when an announcement is released.
The company is working to raise awareness of its products among mainstream doctors and aims to reach 1,000 patients by this time next year.
The life science company is developing products for the e-cigarette liquid market as well as for the food additive and supplement markets.